Chen Franco-Yehuda
2020
In 2020, Chen Franco-Yehuda earned a total compensation of $207.7K as CFO at Pluristem Therapeutics, a 1% increase compared to previous year.
Compensation breakdown
| Salary | $179,229 |
|---|---|
| Other | $28,461 |
| Total | $207,690 |
Franco-Yehuda received $179.2K in salary, accounting for 86% of the total pay in 2020.
Franco-Yehuda also received $28.5K in other compensation.
Rankings
In 2020, Chen Franco-Yehuda's compensation ranked 12,557th out of 13,090 executives tracked by ExecPay. In other words, Franco-Yehuda earned more than 4.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,557 out of 13,090 | 4th |
Division Manufacturing | 5,393 out of 5,624 | 4th |
Major group Chemicals And Allied Products | 2,181 out of 2,257 | 3rd |
Industry group Drugs | 1,896 out of 1,957 | 3rd |
Industry Biological Products, Except Diagnostic Substances | 403 out of 411 | 2nd |
Source: SEC filing on April 8, 2021.
Franco-Yehuda's colleagues
We found two more compensation records of executives who worked with Chen Franco-Yehuda at Pluristem Therapeutics in 2020.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020